Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (Suprecu®) (A prospective study)

Journal of Obstetrics and Gynaecology Research

Volumn 25, Issue 3, 1999, Pages 153-164

  Mori, Hiroyuki ^a,f   Taketani, Yuji ^b   Uemura, Tsuguo ^c   Miyake, Akira ^d   Tango, Toshiro ^e  

^a TEIKYO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d Miyake Ladies Clinic   (Japan)

^e NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^f TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometriosis; GnRH agonist; Pregnancy; Recurrence

Indexed keywords

BUSERELIN ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENDOMETRIOSIS; FEMALE; FEMALE STERILITY; HUMAN; INTRANASAL DRUG ADMINISTRATION; JAPAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREGNANCY RATE; RECURRENCE RISK; STATISTICAL ANALYSIS; SYMPTOM;

EID: 0032809966     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.1999.tb01141.x     Document Type: Article

References (11)

1. Tango T, ed. Statistics for medicine. Asakura Shoten, 1983; 193-203
2. Minaguchi H, et al. Clinical evaluation of buserelin in patients with endometriosis - Double-blind comparative study using danazol as a control drug. World Obstet Gynecol 1987; 39: 1159-1188
3. Yoshikawa M, et al. Curative effects of buserelin on endometriosis. World Obstet Gynecol 1987; 39: 787-791
4. Mori H, et al. Clinical effects of buserelin on endometriosis and the influence of buserelin administration on hormone kinetics. Obstet Gynecol 1990; 57: 345-350
5. Ohyama T, et al. Long-term prognosis of endometriosis treatment at our department. J Endometriosis Res Group 1988; 9: 172-174
6. Hirai M, et al. Clinical examination of treatment for endometriosis with various agents. J Endometriosis Res Group 1988; 9: 259-262
7. Mizunuma H, et al. Clinical usefulness of Suprecur® (buserelin acetate) in patients with endometriosis. World Obstet Gynecol 1992; 44: 381
8. Kathleen G, et al. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: Long-term follow-up. Fertil Steril 1993; 59: 511-515
9. Alberto R, et al. Recurrent endometriosis: A review of biological and clinical aspects. Obstet Gynecol Surv 1995; 50: 747-754
10. Regidor PA, et al. Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelin acetate. Eur J Obstet Gynecol Reprod Biol 1997; 73: 153-160
11. Fedele L, et al. Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial. Am J Obstet Gynecol 1992; 166: 1345-1350